Prozac Pediatric Indication Recommended By EU Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
EMEA’s Committee for Medicinal Products for Human Use backed the pediatric depression indication for Lilly’s fluoxetine, but urged continued safety studies.
You may also be interested in...
Antidepressants Should Not Be Used Off-Label In Children, EMEA Says
European Medicines Agency recommends that warnings highlighting the increased risk of suicidal behavior should be included in product information for SSRIs/SNRIs. If the products are used off-label in pediatric populations out of clinical necessity, children should be monitored for suicidal behavior, the agency says.
Antidepressant MedGuide Distribution Imminent; Unit-Of-Use Packs To Follow
The new patient Medication Guide is expected to reach pharmacies the week of March 7. The standardized MedGuides will be issued as tear-off pads for about a year until manufacturers implement unit-of-use packaging, which would allow the guide to be pre-packaged with every prescription.
Tarceva Pancreatic Cancer Indication Turned Down In The EU
Roche will consider requesting a re-examination of the negative decision by the Committee for Medicinal Products for Human Use.